Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP 501 (Amjevita) vs Adalimumab in Plaque Psoriasis
NCT01970488Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Amgen. Started Oct 2013; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01970488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970488.